Vitamin D deficiency in schizophrenia implications for COVID-19 infectionReview Article Published on 2020-09-112022-10-30 Journal: Irish Journal of Psychological Medicine [Category] COVID-19, SARS, [키워드] 25 (OH)D Acute respiratory infection Antipsychotics association COVID-19 COVID-19 infection death deficiency Evidence immune immunomodulatory implication increased risk mechanism of action offer Pneumonia Prevalence prevalent Psychosis reduce Research respiratory infection risk risk factor risk of COVID-19 Schizophrenia severity vitamin D deficiency vitamin D level [DOI] 10.1017/ipm.2020.107 PMC 바로가기 [Article Type] Review Article
Treatment concerns for psychiatric symptoms in patients with COVID-19 with or without psychiatric disordersEditorial Published on 2020-04-092022-10-28 Journal: The British Journal of Psychiatry [Category] Coronavirus, SARS, [키워드] Antipsychotics Antiviral antiviral drugs Combination coronavirus develop drug interactions and side-effects infected with COVID-19 interactions P450 Patient patients with COVID-19 Psychiatric psychiatric disorder psychotic disorders Safe Symptom Tolerability Treatment [DOI] 10.1192/bjp.2020.84 PMC 바로가기 [Article Type] Editorial
Epidemiology of schizophrenia and its management over 8-years period using real-world data in SpainResearch Article Published on 2020-04-052024-09-02 Journal: BMC Psychiatry [Category] 대상포진, [키워드] Antipsychotics Epidemiolgy incidence Prevalence Real world data Schizophrenia [DOI] 10.1186/s12888-020-02538-8 PMC 바로가기 [Article Type] Research Article
HyperprolactinaemiaReview Published on 2019-12-132024-09-02 Journal: Journal of Clinical Medicine [Category] 대상포진, [키워드] Antipsychotics dopamine agonists hyperprolactinaemia hypogonadism Prolactin prolactinoma [DOI] 10.3390/jcm8122203 PMC 바로가기 [Article Type] Review